Quantcast
Last updated on April 20, 2014 at 7:40 EDT

Latest diarrhea Stories

2012-03-06 11:19:00

CDC highlights steps to prevent spread of deadly C. difficile bacteria, which impacts patients in nursing homes and outpatient care, not just hospitals ATLANTA, March 6, 2012 /PRNewswire-USNewswire/ -- Infections from Clostridium difficile (C. difficile), a bacteria that causes diarrhea and other health issues, is a patient safety concern in all types of medical facilities, not just hospitals as traditionally thought, according to a new Vital Signs report today from the Centers for...

2012-02-10 06:00:00

PRINCETON, N.J., Feb. 10, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGXD) (Soligenix or the Company), a development stage biopharmaceutical company, announced preliminary results today from a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), for the prevention of acute radiation enteritis. The Phase 1/2 protocol BDP-ENT-01 was designed as an open label, randomized, dose-finding study at five centers. Sixteen...

2012-01-27 14:39:00

SAN DIEGO and DUBLIN, Jan. 27, 2012 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved BYDUREON(TM) (exenatide extended-release for injectable suspension) - the first once-weekly treatment for type 2 diabetes. BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2...

119631101
2012-01-27 09:57:03

Persistent bacterial infections can make a mess of our bowels and the usual treatment method of adding antibiotics usually causes even more disruptions. Researchers, however, are fine tuning a treatment that involves adding a sample of the stool of another which jump-starts the infected patients immune system, reports Kerry Grens for Reuters Health. The procedure is used primarily to treat patients with infections from the bacterium Clostridium difficile. “It´s unbelievably...

2012-01-25 12:46:47

'When traveling in the tropics, my IBD felt the best ever,' recall patients Inflammatory bowel disease (IBD) travelers have an increased risk of illness during trips to industrialized countries, but not to developing or tropical regions, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Inflammatory bowel disease patients are often advised to avoid travel, especially to the developing world....

2012-01-10 09:40:00

PHILADELPHIA, January 10, 2012 /PRNewswire/ -- - Agreement allows development for potential treatment of chronic constipation Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor(R) (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V. Terms of the agreement have not been disclosed. Resolor, a prokinetic, is part of...

2012-01-10 06:00:00

PHILADELPHIA, January 10, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor(R) (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V. Terms of the agreement have not been disclosed. Resolor, a prokinetic, is part of Shire's gastrointestinal (GI) portfolio in Europe and is approved for use in 33 countries...

2012-01-05 15:30:00

EXTON, Pa., Jan. 5, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will provide an overview of the company's business during the 30th Annual J.P. Morgan Healthcare Conference. The presentation will be webcast live at 7:30 P.M. ET (4:30 P.M. PT) on Tuesday, January 10, 2012 and may be accessed via the company's website at www.viropharma.com. The conference is being...

2012-01-04 15:48:41

The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. "Insight into the worldwide epidemiology of inflammatory bowel disease is important for the identification of geographic patterns and time trends," said Gilaad G. Kaplan, MD, MPH, of the University of Calgary and lead author of this study. "Our...

2011-12-13 09:00:00

LEXINGTON, Mass., Dec. 13, 2011 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company was awarded U.S. Patent 8,071,101, "Antibody Therapy for Treatment of Diseases Associated With Gluten Intolerance." This patent, which expires on May 27, 2029, provides broad coverage for treating celiac disease using orally administered antibodies produced by the...


Latest diarrhea Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

11_f79bc6a70a3ca6d0849bbfc3e310d871
2011-02-23 20:42:46

Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...

45_7b9aa20b6263a73b7fcd4e869f868330
2011-02-17 17:29:15

Norovirus is an RNA virus that causes approximately 90% of epidemic non-bacterial outbreaks of gastroenteritis around the world. It may also be responsible for 50% of all foodborne outbreaks of gastroenteritis in the U.S. It can affect people of all ages and is transmitted by food or water that is contaminated, by person-to-person contact, and through aerosolization of the virus and subsequent contamination of surfaces. Immunity is usually incomplete and temporary after infection. People...

More Articles (3 articles) »